Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Dosis-Wirkungsbeziehungen von Allopurinol

  • 11 Accesses

This is a preview of subscription content, log in to check access.


  1. 1.

    Löffler W, Gröbner W (1988) A study of dose-response relationships of allopurinol in the presence of low or high purine turnover. Klin Wochenschr 66:153–159

  2. 2.

    Mertz DP (1977) Zur Dosis-Wirkungs-Beziehung von Allopurinol. Arzneimittel-Forsch 27:1209–1211

  3. 3.

    Mertz DP, Loewer H (1979) Wirkungsprofil der Harnsäuresenkung bei Höherdosierung von Allopurinol. Dtsch med Wochenschr 104:324–325


  1. 1.

    Cameron JS, Simmonds HA, Morris GS (1986) The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency. Adv Exp Med Biol 195A:435–440

  2. 2.

    Elion GB, Kovensky A, Hitchings GH, Metz E, Rundles RW (1966) Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 15:863–880

  3. 3.

    Ellion GB, Yü TF, Gutman AB, Hitchings GH (1968) Renal clearance of oxipurinol, the chief metabolite of allopurinol. Amer J Med 45:69–77

  4. 4.

    Hande KR, Noone RM, Stone WJ (1984) Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Amer J Med 76:47–56

  5. 5.

    Singer JZ, Wallace SL (1986) The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthr Rheum 29:82–87

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mertz, D.P. Dosis-Wirkungsbeziehungen von Allopurinol. Klin Wochenschr 66, 747–748 (1988).

Download citation